Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma [0.03%]
中药天麻中天然化合物治疗黑色素瘤的研究进展
Xin Li,Lankang Wang,Baoyi Ni et al.
Xin Li et al.
Melanoma is a malignant tumor that originates from activated or genetically altered epidermal melanocytes, resulting from the interplay of genetic, somatic, and environmental factors. It is the fastest-growing malignancy among the Caucasian...
Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy [0.03%]
包括放射治疗作用的四期宫颈癌的管理
Ulysses G Gardner,Akila N Viswanathan
Ulysses G Gardner
The treatment of stage IVB cervical cancer is undergoing a paradigm shift, moving beyond palliation toward strategies that may improve survival rates in select patients. Radiation therapy is a key component of this shift, not only for local...
Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma [0.03%]
上皮样血管内皮瘤：一种超罕见肉瘤的治疗格局和创新疗法
Erica M Pimenta,Anirudh Goyal,Orly N Farber et al.
Erica M Pimenta et al.
Epithelioid hemangioendothelioma (EHE) is an ultra-rare sarcoma with a paucity of data on best practices for management. Pathogenic translocations involving the YAP or TAZ genes lead to constitutive activation of TEAD and TEAD-associated pa...
Addressing Sexual Health in Breast Cancer Survivors: Evidence-Based Practices and Clinical Considerations [0.03%]
乳腺癌幸存者性健康的临床考量及实证方法
Laila S Agrawal
Laila S Agrawal
Sexual health concerns are extremely prevalent among breast cancer survivors. The treatments used to treat and cure breast cancer - surgical removal of part or the whole breast, chemotherapy, radiation, and endocrine therapy - can have deva...
Kabir Grewal,Tanya B Dorff,Sagar S Mukhida et al.
Kabir Grewal et al.
Over the past few years, treatment for advanced prostate cancer has begun shifting away from a one-size-fits-all approach toward biomarker-based therapies for select groups of patients. This review highlights the role of poly-ADP-ribose-pol...
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy [0.03%]
复发/难治性弥漫大B细胞淋巴瘤治疗进展：嵌合抗原受体T细胞疗法的作用
Vibor Milunović,Dora Dragčević,Martina Bogeljić Patekar et al.
Vibor Milunović et al.
Diffuse large B cell lymphoma, not otherwise specified (DLBCL-NOS) is the most common aggressive lymphoma and can be cured with CHOP-R immunochemotherapy in 60% of cases. The second-line therapy includes salvage regimens followed by autolog...
Locoregional Non-Surgical Treatments for Unresectable or Oligometastatic Sarcomas: A Literature Review [0.03%]
不可手术或寡转移性肉瘤的局部区域非手术治疗：文献综述
Annarita Peddio,Antonio Pizzolorusso,Ottavia Clemente et al.
Annarita Peddio et al.
Sarcomas are rare neoplasms, whose complex management is a consequence of their heterogeneity. Due to their variegate histology and characteristics, prospective trials are challenging to design. Thus, diagnostic and therapeutic guidelines a...
Combination Immunotherapy for Mucosal Melanoma: Molecular Mechanism, Research Status, and Future Directions [0.03%]
黏膜黑色素瘤的免疫联合治疗：分子机制、研究现状与未来方向
Jie Yang,Xuerui Wang,Yuan Meng et al.
Jie Yang et al.
Mucosal melanoma is a rare and aggressive subtype of melanoma, accounting for 1%-2% of new cases in the United States in 2023, and 20%-30% in China and other Asian countries. Its origin is often occult, with the lack of early clinical featu...
PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future [0.03%]
基于PSMA的疗法和新型疗法在晚期前列腺癌中的应用：现状与未来
Ann Ayzman,Russell K Pachynski,Melissa A Reimers
Ann Ayzman
The treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) is rapidly evolving with the advent of PSMA-targeted radioligand therapies (RLTs) and bispecific T-cell engagers (BiTEs). These novel approaches provide new...
Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook [0.03%]
不可切除性胸膜间皮瘤电场治疗(TTFields)疗效、安全性及未来展望的综述分析
Giovanni Luca Ceresoli,Letizia Gianoncelli
Giovanni Luca Ceresoli
Pleural mesothelioma is an incurable cancer with unmet diagnostic and therapeutic needs. Due to its pattern of local spread, few patients are candidates for multimodality treatment and thus most patients only receive systemic therapy. Chemo...